A case of fixed drug eruption induced by tegafur-uracil(tegasil)
- Authors
- Heo, Y.S.; Song, H.J.; Oh, C.H.
- Issue Date
- 2010
- Keywords
- Fixed drug eruption; Tegafur; Tegasil
- Citation
- Korean Journal of Dermatology, v.48, no.2, pp.155 - 157
- Indexed
- SCOPUS
KCI
- Journal Title
- Korean Journal of Dermatology
- Volume
- 48
- Number
- 2
- Start Page
- 155
- End Page
- 157
- URI
- https://scholar.korea.ac.kr/handle/2021.sw.korea/118301
- ISSN
- 0494-4739
- Abstract
- A mixture of tegafur and uracil (TEGASIL) is a common antineoplastic agent. Tegafur is a fluoropyrimidine structurally similar to 5-fluorouracil (5-FU); uracil slows the degradation of 5-FU by dihydropyrimidine dehydrogenase, which results in higher 5-FU concentrations in tumors. Mucocutaneous side effects induced by this agent are rare and include photosensitivity of lichenoid and eczematous types, acral erythema, hyperpigmentation and palmoplantar keratoderma. However, there have been no reports of fixed drug eruption associated with TEGASIL. We report here on a case of fixed drug eruption due to oral TEGASIL. (Korean J Dermatol 2010;48(2):155-157).
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Medicine > Department of Medical Science > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.